Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-22-053836

EVP, Chief Operating Officer gave up 2,012 shares (to pay taxes)

  • EVP, Chief Operating Officer acquired 5,814 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Szekeres David Leslie EVP, Chief Operating Officer 2022-10-13 Option exercise +1,250 18,142 D
Szekeres David Leslie EVP, Chief Operating Officer 2022-10-13 Option exercise +4,564 22,706 D
Szekeres David Leslie EVP, Chief Operating Officer 2022-10-13 Shares withheld for taxes −2,012 $3.76 $7,565 20,694 D
Derivatives
Szekeres David Leslie EVP, Chief Operating Officer 2022-10-13 Option exercise · Restricted Stock Units −1,250 10,000 D
Szekeres David Leslie EVP, Chief Operating Officer 2022-10-13 Option exercise · Restricted Stock Units −4,564 37,064 D
Loading xslF345X03/doc4.xml…